What is the main business of Świt Pharma?

The main business activity of Świt Pharma focuses on manufacture of perfumes and toilet preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 10, 2004.

Where is the headquarters located?

The headquarters is located at: Taśmowa 1, 02-677 Warszawa.

What is the share capital?

The share capital of the company is PLN 4,010,000 (approx. $1.1 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $2,738,087 in 2024, which is a decrease of 29.4% compared to 2023.

Is the company profitable?

Yes, the company recorded a net profit of $431,746 in 2024, meaning the company increased its profit by 304.7%.

What is the main operating cost?

The largest operating cost category falls under materials and energy. This category amounted to $1,684,827 in 2024, representing 76% of all operating expenses.

Świt Pharmasp. z o.o.

Manufacture of perfumes and toilet preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2004-02-10

Share capital

4 010 000,00 PLN

Activity description

Świt Pharma operates a shop selling L'Adore women's eau de parfum, including Enchanté and Rose Désir. Its range also includes travel sets and Sol de Salvador body mists in scents such as flowers and amber, coffee and vanilla, and coconut and praline.

Registered address

Taśmowa 1, 02-677 Warszawa, Poland

Website

switpharma.pl

Phone

Social media

Electronic delivery address

AE:PL-96283-36965-FRVUV-26

Financials

2 of the last 5 financial statements were filed late.

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 4.95mMedianUSD 178.92kAverageUSD 6.85m

Net profit

This companyUSD 757.59kMedianUSD 2.15kAverageUSD 464.59k

Operating costs

This companyUSD 3.35mMedianUSD 175.18kAverageUSD 6.09m

Assets

This companyUSD 10.15mMedianUSD 162.07kAverageUSD 5.65m

Industry

Bank accounts

Registered as a VAT taxpayer on 2004-08-26.

Deutsche Bank Polska
66 1910 1048 2787 0365 9256 0002
VeloBank
07 1560 0013 2022 3364 6000 0003
Deutsche Bank Polska
12 1910 1048 2787 0365 9256 0004

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $26,555.

Grant date	Purpose	Gross amount	Granting body
Mar 4, 2021	Aid in the form of wage subsidies for the recruitment of disadvantaged workers	$6,862$6,862	Dyrektor Generalny Służby Więziennej
Dec 13, 2019	Aid to facilitate the development of certain economic activities or of certain economic areas, where such aid does not adversely affect trading conditions to an extent contrary to the common interest	$5,668$5,668	Dyrektor Generalny Służby Więziennej
Aug 14, 2019	Aid to facilitate the development of certain economic activities or of certain economic areas, where such aid does not adversely affect trading conditions to an extent contrary to the common interest	$5,029$5,029	Dyrektor Generalny Służby Więziennej

Trademarks

Świt Pharma holds 1 active trademark registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2017.

Mark	Number	Classes	Status	Protected until
SKRZAT(word)	Z.492435	3, 16, 21, 24	Protected	Nov 7, 2028
NEXXOGENE(word)	Z.479409	3	Not registered	–

Mark	Protected until
SKRZAT(word)	Nov 7, 2028
NEXXOGENE(word)	–

Authorized Representatives

Paulina Braun – Vice President of the Management Board

Waldemar Zbigniew Siwak – President of the Management Board

Manner of representation

To make declarations of will concerning the company's proprietary rights and obligations, incur obligations and sign agreements on its behalf, the following are authorized: a) two members of the management board acting jointly; b) one member of the management board acting jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Spółdzielnia Inwalidów Świt	80,000	$1,080,497.03	99.7506%
Others	200	$2,701.24	0.2494%

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
Glantiersp. z o.o.	$13,941,049.75	glantier.com
Flosleksp. z o.o.	$10,990,930.54	floslek.pl
Saraya Polandsp. z o.o.	$9,470,621.97	saraya.pl
City Cosmeticssp. z o.o.	$4,371,889.50	city-cosmetics.pl
NoweS.A.	$4,141,588.15	nowegroup.com.pl
Grehensp. z o.o.	$4,088,090.26	charminerose.eu
Jacques Battini Cosmeticssp. z o.o.	$3,704,414.82	jacquesbattini.pl
KALAsp. z o.o.	$3,612,506.28	kala.pl
Miracansp. z o.o.	$3,146,011.90	miracan.pl
Laboratorium Ambroziaksp. z o.o.	$1,854,134.54	drambroziak.com

Change history

Date	Event
2016-08-16	PKD change (Removed: 17.11.Z, 17.12.Z, 17.21.Z, 17.22.Z, 17.23.Z, 17.24.Z, 17.29.Z, 18.11.Z, 18.12.Z, 18.13.Z, 18.14.Z, 18.20.Z, 20.30.Z, 20.52.Z, 20.53.Z, 21.10.Z, 21.20.Z, 22.21.Z, 22.23.Z, 22.29.Z, 25.61.Z, 25.99.Z, 41.10.Z, 41.20.Z, 42.11.Z, 42.22.Z, 43.11.Z, 43.12.Z, 43.13.Z, 43.21.Z, 43.22.Z, 43.29.Z, 43.31.Z, 43.32.Z, 43.33.Z, 43.34.Z, 43.39.Z, 43.91.Z, 43.99.Z, 46.11.Z, 46.12.Z, 46.13.Z, 46.14.Z, 46.15.Z, 46.16.Z, 46.17.Z, 46.18.Z, 46.19.Z, 46.31.Z, 46.32.Z, 46.33.Z, 46.34.A, 46.34.B, 46.35.Z, 46.36.Z, 46.37.Z, 46.39.Z, 46.41.Z, 46.42.Z, 46.43.Z, 46.44.Z, 46.47.Z, 46.48.Z, 46.49.Z, 46.51.Z, 46.52.Z, 46.61.Z, 46.62.Z, 46.63.Z, 46.64.Z, 46.65.Z, 46.66.Z, 46.71.Z, 46.72.Z, 46.73.Z, 46.74.Z, 46.76.Z, 46.77.Z, 46.90.Z, 47.73.Z, 47.74.Z, 47.75.Z, 49.41.Z, 49.42.Z, 52.21.Z, 52.22.A, 52.22.B, 52.23.Z, 52.29.C, 69.20.Z, 70.21.Z, 70.22.Z, 72.11.Z, 72.20.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D, 73.20.Z, 74.30.Z, 82.11.Z, 82.19.Z, 82.91.Z, 82.92.Z, 82.99.Z, 86.90.D, 86.90.E, 87.20.Z, 87.30.Z, 88.10.Z, 96.09.Z)
2015-01-08	Share capital change (4,000,000.00 PLN → 4,010,000.00 PLN)
2014-09-17	Name change ("świt" → Świt Pharma)
2012-08-06	PKD change (Removed: 01.1, 21.2, 22.1, 22.2, 24.1, 24.4, 24.5, 24.6, 25.1, 25.2, 26.6, 28.51.Z, 28.7, 29.5, 36.50.Z, 45, 51.1, 51.2, 51.3, 51.4, 51.5, 51.70, 52.3, 52.4, 52.6, 60.24, 63.11, 63.12, 63.21.Z, 73.10, 74.40.Z, 74.83.Z, 74.84.B, 85..N, 93.05.Z; Added: 17.11.Z, 17.12.Z, 17.21.Z, 17.22.Z, 17.23.Z, 17.24.Z, 17.29.Z, 18.11.Z, 18.12.Z, 18.13.Z, 18.14.Z, 18.20.Z, 20.30.Z, 20.41.Z, 20.42.Z, 20.52.Z, 20.53.Z, 20.59.Z, 21.10.Z, 21.20.Z, 22.21.Z, 22.22.Z, 22.23.Z, 22.29.Z, 25.61.Z, 25.99.Z, 41.10.Z, 41.20.Z, 42.11.Z, 42.22.Z, 43.11.Z, 43.12.Z, 43.13.Z, 43.21.Z, 43.22.Z, 43.29.Z, 43.31.Z, 43.32.Z, 43.33.Z, 43.34.Z, 43.39.Z, 43.91.Z, 43.99.Z, 46.11.Z, 46.12.Z, 46.13.Z, 46.14.Z, 46.15.Z, 46.16.Z, 46.17.Z, 46.18.Z, 46.19.Z, 46.31.Z, 46.32.Z, 46.33.Z, 46.34.A, 46.34.B, 46.35.Z, 46.36.Z, 46.37.Z, 46.39.Z, 46.41.Z, 46.42.Z, 46.43.Z, 46.44.Z, 46.45.Z, 46.46.Z, 46.47.Z, 46.48.Z, 46.49.Z, 46.51.Z, 46.52.Z, 46.61.Z, 46.62.Z, 46.63.Z, 46.64.Z, 46.65.Z, 46.66.Z, 46.69.Z, 46.71.Z, 46.72.Z, 46.73.Z, 46.74.Z, 46.75.Z, 46.76.Z, 46.77.Z, 46.90.Z, 47.73.Z, 47.74.Z, 47.75.Z, 49.41.Z, 49.42.Z, 52.10.B, 52.21.Z, 52.22.A, 52.22.B, 52.23.Z, 52.29.C, 69.20.Z, 70.21.Z, 70.22.Z, 72.11.Z, 72.20.Z, 73.11.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D, 73.20.Z, 74.30.Z, 82.11.Z, 82.19.Z, 82.91.Z, 82.92.Z, 82.99.Z, 86.90.D, 86.90.E, 87.20.Z, 87.30.Z, 88.10.Z, 96.09.Z)
2006-07-03	Share capital change (2,804,000.00 PLN → 4,000,000.00 PLN)

FAQ

Last updated: 2026-07-17